A study of PD-L1 expression in KRAS mutant non-small cell lung cancer cell lines exposed to relevant targeted treatments-Reference-Cited by-同舟云学术

A study of PD-L1 expression in KRAS mutant non-small cell lung cancer cell lines exposed to relevant targeted treatments

Published:2017-10-05 Issue:10 Volume:12 Page:e0186106
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Minchom Anna^ORCID,Thavasu Parames,Ahmad Zai,Stewart Adam,Georgiou Alexandros,O’Brien Mary E. R.,Popat Sanjay,Bhosle Jaishree,Yap Timothy A.,de Bono Johann,Banerji Udai

Funder

National Institute for Health Research Biomedical Research Centre

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference26 articles.

1. Global cancer statistics, 2012;LA Torre;CA Cancer J Clin,2015

2. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma;TS Mok;New Eng J Med,2009

3. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy;JG Paez;Science,2004

4. Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial;K Park;Lancet Oncol,2016

5. First-line crizotinib versus chemotherapy in ALK-positive lung cancer;BJ Solomon;New Eng J Med,2014

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correlation between immunotherapy biomarker PD-L1 expression and genetic alteration in patients with non-small cell lung cancer;Genomics;2023-07

2. Correlation between PD-L1 expression of the tumour cells and lymphocytes infiltration in the invasive front of urothelial carcinoma;Journal of Clinical Pathology;2022-11-01

3. MERTK Inhibition: Potential as a Treatment Strategy in EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer;Pharmaceuticals;2021-02-06

4. LncRNA-ATB Can Be a Biomarker for Diagnosis and Prognosis Evaluation of Non-Small Cell Lung Cancer;Oncologie;2020-12-30

5. Spatiotemporal metabolic dynamics of the photosensitizer talaporfin sodium in carcinoma and sarcoma;Cancer Science;2020-12-04